Anzeige
Mehr »
Sonntag, 26.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C2U | ISIN: US45720N1037 | Ticker-Symbol:
NASDAQ
24.10.25 | 22:00
57,29 US-Dollar
+102,01 % +28,93
1-Jahres-Chart
INHIBRX BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
INHIBRX BIOSCIENCES INC 5-Tage-Chart

Aktuelle News zur INHIBRX BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrMorning Market Movers: Picard Medical, Qualigen Therapeutics, Inhibrx Biosciences, MidWestOne Financial GroupSee Big Swings385BEIJING (dpa-AFX) - At 7:45 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen
FrWhy Are Inhibrx Biosciences Shares Soaring 76% After Hours?3
DoInhibrx stock soars after positive cancer drug trial results2
DoInhibrx Biosciences, Inc. - 8-K, Current Report1
DoInhibrx Biosciences, Inc.: Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion ...703Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free...
► Artikel lesen
22.08.Citizens JMP reiterates Market Perform rating on Inhibrx Biosciences stock2
13.08.Inhibrx Biosciences, Inc. - 8-K, Current Report3
13.08.Inhibrx Biosciences, Inc.: Inhibrx Reports Second Quarter 2025 Financial Results406SAN DIEGO, Aug. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the second...
► Artikel lesen
INHIBRX BIOSCIENCES Aktie jetzt für 0€ handeln
15.05.Inhibrx Biosciences GAAP EPS of $2.803
15.05.Inhibrx, Inc. Q1 Loss Decreases, Beats Estimates1
14.05.Inhibrx Biosciences, Inc. - 8-K, Current Report1
14.05.Inhibrx Biosciences, Inc.: Inhibrx Reports First Quarter 2025 Financial Results226SAN DIEGO, May 14, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the first...
► Artikel lesen
17.03.Inhibrx Biosciences, Inc.: Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results289SAN DIEGO, March 17, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the fourth...
► Artikel lesen
21.01.Inhibrx Biosciences, Inc.: Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer219 SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused...
► Artikel lesen
14.11.24Inhibrx Biosciences, Inc.: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results305SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx Biosciences" or the "Company") today reported financial results for...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1